Candel Therapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Candel Therapeutics Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Needham
Headquarters state / province: Massachusetts
Headquarters country: United States
Fiscal year end: December
Ticker symbol: CADL
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001841387
EIN: 52-2214851

Board of directors

Follow this board

Christopher Martell · Director
Since 2023
Diem Nguyen · Director
Since 2023
Edward J. Benz Jr. · Director
Since 2023
Estuardo Aguilar-Cordova · Director
Since 2023
Gary J. Nabel · Director
Since 2023
Joseph C. Papa · Director
Since 2023
Maha Radhakrishnan · Director
Since 2025
Martine Zimmermann · Director
Since 2026
Nicoletta Loggia · Director
Since 2023
Paul B. Manning · Director
Since 2023
Paul Peter Tak · Director · Chief Executive Officer
Since 2023
Renee Gaeta · Director
Since 2023

Chief executives

Paul Peter Tak · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of June 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

6 of this board's directors also sit on 9 other boards. 9 are in the same sector.

Shared director Other board Same sector

SIGA Technologies Inc. Same sector
via Diem Nguyen and Gary J. Nabel
Verrica Pharmaceuticals Inc. Same sector
via Diem Nguyen and Paul B. Manning
Alto Neuroscience Inc. Same sector
via Maha Radhakrishnan
Emergent BioSolutions Inc. Same sector
via Joseph C. Papa
Entrada Therapeutics Inc. Same sector
via Maha Radhakrishnan
Ligand Pharmaceuticals Incorporated Same sector
via Martine Zimmermann
Liquidia Corporation Same sector
via Paul B. Manning
Milestone Pharmaceuticals Inc. Same sector
via Joseph C. Papa
OPKO Health Inc. Same sector
via Gary J. Nabel

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $2,999,996; 1 purchase by 1 insider
Sold, last 12 months: $3,551,080; 5 sales by 3 insiders

Date	Insider	Transaction	Shares	Price	Value
Sep 11, 2026	Paul Peter Tak Director, Officer (Chief Executive Officer)	Open-market sale	−59,379	$10.46	$621,104
Sep 10, 2026	Paul Peter Tak Director, Officer (Chief Executive Officer)	Option exercise	+125,000	$1.55	$193,750
Sep 10, 2026	Paul Peter Tak Director, Officer (Chief Executive Officer)	Open-market sale	−220,866	$11.50	$2,539,959
Aug 17, 2026	Tyagarajan Seshu Officer (Chief Technology Officer)	Open-market sale	−7,000	$12.00	$84,000
Jun 29, 2026	Barone Francesca Officer (Chief Scientific Officer)	Open-market sale	−23,447	$10.06	$235,877
Jun 29, 2026	Tyagarajan Seshu Officer (Chief Technology Officer)	Open-market sale	−7,000	$10.02	$70,140
Feb 23, 2026	Paul B. Manning Director	Open-market purchase	+550,458	$5.45	$2,999,996
Jul 28, 2025	Nichols William Garrett Officer (Chief Medical Officer)	Option exercise	+937	$1.29	$1,209
Jul 28, 2025	Nichols William Garrett Officer (Chief Medical Officer)	Open-market sale	−937	$6.98	$6,540
Jun 30, 2025	Nichols William Garrett Officer (Chief Medical Officer)	Option exercise	+781	$1.29	$1,007
Jun 30, 2025	Nichols William Garrett Officer (Chief Medical Officer)	Open-market sale	−781	$5.04	$3,936
Jun 25, 2025	Tyagarajan Seshu Officer (Chief Technology Officer)	Grant or award	+5,353	$4.67	$24,999
Jun 25, 2025	Paul Peter Tak Director, Officer (Chief Executive Officer)	Grant or award	+42,826	$4.67	$199,997
Jun 25, 2025	Paul B. Manning Director	Grant or award	+1,070,663	$4.67	$4,999,996
Jun 25, 2025	Christopher Martell Director	Grant or award	+111,349	$4.67	$520,000

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Candel Therapeutics Inc.

Who is the CEO of Candel Therapeutics Inc.?

Paul Peter Tak is Candel Therapeutics Inc.'s Chief Executive Officer.

How many directors are on Candel Therapeutics Inc.'s board?

Candel Therapeutics Inc.'s board has 12 directors: Christopher Martell, Diem Nguyen, Edward J. Benz Jr., Estuardo Aguilar-Cordova, Gary J. Nabel, Joseph C. Papa, Maha Radhakrishnan, Martine Zimmermann, Nicoletta Loggia, Paul B. Manning and 2 others.

Are Candel Therapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Candel Therapeutics Inc. insiders bought $3.0 million of shares in 1 purchase and sold $3.6 million of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Candel Therapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="candel-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.